Log In
BCIQ
Print this Print this
 

EDO-B278

  Manage Alerts
Collapse Summary General Information
Company Mundipharma International Ltd.
DescriptionAntibody-drug conjugate (ADC) against tissue factor (TF; CD142) (thromboplastin)
Molecular Target Tissue factor (TF) (CD142) (thromboplastin)
Mechanism of ActionAntibody-drug conjugate
Therapeutic ModalityBiologic: Antibody-drug conjugate
Latest Stage of DevelopmentDiscovery
Standard IndicationSolid tumors
Indication DetailsTreat solid tumors
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today